BlackBerry didn't announce how much it invested in the company which creates a software platform that's used by about 250 hospitals and gather data from more than 16,000 connected medical devices.
The two companies will work together to create a smartphone for the healthcare industry that's optimized for viewing 3D images and CT scans. The smartphone will ship in later 2014 or early 2015. NantHealth also said it will use BlackBerry's QNX OS to "put the power of a supercomputer in the palm of the caregiver's hand."
"This investment and planned collaboration aligns with the reliability, security and versatility of BlackBerry's end-to-end solutions - from the embedded QNX operating system powering complex medical devices, to secure cloud-based networks, to instantaneous information sharing over BBM Protected," BlackBerry CEO and executive chair John Chen said in a press release.
Must read: Warren Buffett's 10 Favorite Growth Stocks
TheStreet Ratings team rates BLACKBERRY LTD as a Sell with a ratings score of D. TheStreet Ratings Team has this to say about their recommendation:
"We rate BLACKBERRY LTD (BBRY) a SELL. This is driven by some concerns, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income, disappointing return on equity, weak operating cash flow and generally disappointing historical performance in the stock itself."